According to a new report, published by KBV research, The Global Ultrasound Transducer Market size is expected to reach $4.9 billion by 2030, rising at a market growth of 3.6% CAGR during the forecast period. In the year 2022, the market attained a volume of 1,933.9 thousand units, experiencing a growth of 4.0% (2019-2022).
The Linear segment is exhibiting a CAGR of 3.3% during (2023 - 2030). Linear transducers are renowned for their ability to produce high-resolution images with exceptional clarity. They are well-suited for imaging superficial structures, such as blood vessels, tendons, and musculoskeletal tissues. This high level of detail is particularly valuable for diagnosing conditions that affect these structures. The use of ultrasound in musculoskeletal imaging has been on the rise, driven by the increasing prevalence of sports-related injuries, orthopedic conditions, and the need for real-time guidance during procedures like joint injections.
The Hospital segment is leading the Global Ultrasound Transducer Market by End Use in 2022; thereby, achieving a market value of $1.7 billion by 2030. Hospitals encompass a diverse range of medical specialties, from obstetrics and gynecology to cardiology, radiology, internal medicine, surgery, and emergency medicine. Ultrasound transducers are versatile and applicable across these specialties, allowing hospitals to utilize them for various diagnostic and monitoring purposes. Ultrasound technology plays a crucial role in providing comprehensive patient care within hospitals. It allows for non-invasive and real-time imaging, aiding in diagnosing and managing medical conditions across different patient demographics.
The Vascular segment is registering a CAGR of 4.8% during (2023 - 2030). Early detection of vascular issues is critical for timely interventions and improved patient outcomes. Vascular ultrasound transducers allow healthcare providers to identify problems like arterial plaque buildup and venous insufficiency at their early stages. Vascular ultrasound provides real-time blood flow imaging, enabling healthcare providers to assess blood circulation dynamics. This real-time monitoring is crucial during vascular surgeries, endovascular interventions, and dialysis access evaluations.
The North America region dominated the Global Ultrasound Transducer Market by Region in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $1.7 billion by 2030. The Europe region is poised to grow at a CAGR of 3.4% during (2023 - 2030). Additionally, The Asia Pacific region would witness a CAGR of 4.5% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/ultrasound-transducer-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country-wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of GE HealthCare Technologies, Inc., Siemens Healthineers AG (Siemens AG), FUJIFILM Sonosite, Inc. (Fujifilm Holdings Corporation), Canon, Inc. (Canon Medical Systems Corporation), Hitachi, Ltd. (Hitachi Healthcare), SonoScape Medical Corp., Koninklijke Philips N.V., Samsung Electronics Co., Ltd. (Samsung Group) (Samsung Medison Co., Ltd.), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. and Esaote SpA.
By Product Type (Volume, Thousand Units, USD Million, 2019-2030)
By End Use (Volume, Thousand Units, USD Million, 2019-2030)
By Application (Volume, Thousand Units, USD Million, 2019-2030)
By Geography (Volume, Thousand Units, USD Million, 2019-2030)
Companies Profiled
Unique Offerings 
